NSE மற்றும் BSE-யின் ஒவ்வொரு கார்ப்பரேட் அறிவிப்பும், AI-யால் சில நிமிடங்களில் படிக்கப்பட்டு விளக்கப்படுகிறது — தாக்கம், முக்கிய புள்ளிவிவரங்கள், குறுகிய/நீண்டகாலப் பார்வை, கவனிக்க வேண்டியவை.
நேரலைசமீபத்திய அறிவிப்பு: 2026-10-16 18:26இன்று 56 பகுப்பாய்வு செய்யப்பட்டது
குறிப்பு: இவை NSE பொது அறிக்கைகளின் AI-உருவாக்கிய, கல்வி நோக்கச் சுருக்கங்கள் — ஒவ்வொரு ஆவணத்தையும் ஆதாரமாகக் கொண்டவை, ஆனால் முதலீட்டு ஆலோசனை அல்ல, மேலும் முழுமையற்றதாகவும் இருக்கலாம். அசல் அறிக்கையுடன் சரிபார்க்கவும், செயல்படுவதற்கு முன் SEBI-பதிவு பெற்ற முதலீட்டு ஆலோசகரை அணுகவும்.
HOMRE Q2 FY27 Standalone Revenue Surges to ₹20.95 Cr; PAT Rises to ₹0.68 Cr
HOMRE Ltd reported standalone revenue from operations of ₹2,094.86 lakhs (₹20.95 cr) for Q2 FY27 (quarter ended Sep 30, 2026), compared to ₹244.80 lakhs in Q2 FY26, representing an over 8-fold increase. Net profit for the quarter came in at ₹68.46 lakhs (₹0.68 cr), up from ₹16.10 lakhs in the corresponding quarter last year. For the first half (H1 FY27), total revenue reached ₹3,287.15 lakhs with a net profit of ₹131.92 lakhs. Despite profitable accruals, cash flow from operations for H1 was negative at -₹67.65 lakhs, impacted by trade receivable additions.
உச்சம் நம்பிக்கை
என்ன மாறியதுHOMRE approved its un-audited financial results for Q2 and H1 ended September 30, 2026, delivering substantial year-on-year revenue and profit expansion.
ஏன் இது முக்கியம்The company's quarterly top-line of ₹20.95 cr significantly exceeds its full-year FY26 revenue (₹15.29 cr), indicating a sharp operational ramp-up.
Revenue from operations (Q2): ₹2,094.86 லட்சம்Net profit (Q2): ₹68.46 லட்சம்H1 FY27 Revenue vs FY26 Full Year: ~215%Basic EPS (Q2): 0.034Cash generated from operations (H1): -₹67.65 lakhs
📅 குறுகிய காலம்The strong top-line and net profit expansion provide positive operational momentum following several quarters of lean revenue.
📈 நீண்ட காலம்Sustainability depends on whether the business can consistently run trading/operating volumes above ₹20 cr quarterly and improve operating cash flow generation.
High trade receivables expansion (absorbing ₹199.89 lakhs in working capital)
Extremely thin net margin profile typical of high-volume trading activities
👀 கவனிக்க வேண்டியவை
Track whether the strong quarterly revenue scale is sustained in H2 FY27 and monitor working capital collection to convert profits into positive operating cash flows.
HOMRE Ltd submitted clarified proceedings of its 36th AGM held on September 24, 2026, following an initial reporting delay flagged by BSE. Shareholders approved the issuance of 5,41,12,552 fully convertible warrants at ₹2.31 per warrant on a preferential basis, raising ₹12.50 crore. This fundraise represents approximately 30% of the company's current market capitalization of ₹42 crore. Additionally, shareholders approved the HOMRE ESOP 2026 scheme comprising up to 3 crore options.
உச்சம் நம்பிக்கை
என்ன மாறியதுHOMRE Ltd submitted a clarification regarding delayed submission alongside the detailed 36th AGM proceedings where all resolutions were approved.
ஏன் இது முக்கியம்The approval of ₹12.50 crore in convertible warrants provides growth capital relative to HOMRE's ₹11 crore net worth, but brings future equity dilution.
Warrant issue value: ₹12,49,99,997Warrant issue price: ₹2.31 per warrantNumber of warrants: 5,41,12,552ESOP options approved: 3,00,00,000Warrants value vs Market Cap: ~29.8%
📅 குறுகிய காலம்Exchanges are likely to take the clarification on record without material impact, while markets digest the equity dilution terms.
📈 நீண்ட காலம்If successfully converted, the ₹12.50 crore capital infusion could strengthen HOMRE's ₹11 crore net worth and support expansion in its jewellery business.
⚠ அபாய எச்சரிக்கைகள்
Substantial equity dilution potential from 5.41 crore warrants and 3 crore ESOP options
Procedural compliance delay flagged by stock exchange
👀 கவனிக்க வேண்டியவை
Track the formal scrutinizer voting report and subsequent allotment disclosures for the ₹12.50 crore convertible warrants, along with their dilution effect on existing equity.
HOMRE AGM Approves ₹12.5 Cr Convertible Warrants Issue and 3 Cr ESOP Pool
HOMRE Limited shareholders approved all resolutions at its 36th AGM held on September 24, 2026, with requisite majority. The most significant resolution is the preferential issue of 5,41,12,552 fully convertible warrants at ₹2.31 each, raising approximately ₹12.50 crore. This fundraise represents nearly 30% of the company's current market cap of ₹42 crore and roughly 46% of its TTM revenue of ₹27 crore. Additionally, shareholders approved the HOMRE ESOP 2026 pool of up to 3 crore options and regularized several board appointments.
உச்சம் நம்பிக்கை
என்ன மாறியதுShareholders officially approved a ₹12.50 crore preferential warrant issue, an employee stock option scheme of 3 crore options, and board appointments.
ஏன் இது முக்கியம்The ₹12.50 crore capital infusion significantly strengthens the balance sheet (net worth currently ₹11 crore), though conversion of warrants will lead to sizable equity dilution.
Preferential Warrants Issue Value: ₹12,49,99,997Number of Convertible Warrants: 5,41,12,552Issue Price per Warrant: ₹2.31Fundraise vs Market Cap: ~29.8%ESOP Pool Size: 3,00,00,000 options
📅 குறுகிய காலம்Receipt of application money for the preferential warrants and filing of voting results on BSE.
📈 நீண்ட காலம்The capital will support working capital and business expansion, but full conversion of warrants and ESOPs will cause substantial equity base expansion and dilution.
⚠ அபாய எச்சரிக்கைகள்
Significant potential equity dilution from 5.41 crore warrants and 3.0 crore ESOP options against a micro-cap base
Deployment and execution risk on the incoming funds
👀 கவனிக்க வேண்டியவை
Track the formal allotment of warrants and the timeline for cash inflow, as well as the detailed voting results scrutinizer report expected within two working days.
HOMRE Ltd sets floor price at ₹2.31 for proposed ₹12.50 Cr preferential warrant issue
HOMRE Ltd has determined a floor price of ₹2.31 per warrant for its proposed preferential issue of up to 5,41,12,553 fully convertible warrants. The total proposed fundraise amounts to ₹12,49,99,997 (~₹12.50 Cr), representing approximately 28.4% of the company's current market capitalization of ₹44 Cr. Each warrant is convertible into one equity share of face value ₹1 each. The Relevant Date for determining the minimum pricing under SEBI ICDR Regulations was August 25, 2026.
உச்சம் நம்பிக்கை
என்ன மாறியதுThe company fixed the floor price at ₹2.31 per warrant and specified terms to issue 5.41 Cr warrants to raise ~₹12.50 Cr.
ஏன் இது முக்கியம்The ₹12.50 Cr capital infusion represents ~28.4% of the current market cap and ~46.3% of TTM revenue, providing critical growth capital to strengthen a company currently having low net worth.
Floor price per warrant: ₹2.31Total warrants proposed: 5,41,12,553Total issue size: ₹12,49,99,997Fundraise vs Market Cap: ~28.4%Relevant Date: 25 ஆகஸ்ட் 2026
📅 குறுகிய காலம்The floor price of ₹2.31 is at a premium to the current market price of ₹1.90, which may provide positive sentiment.
📈 நீண்ட காலம்Successful capital infusion can improve the balance sheet and scale operations, offset by equity dilution upon full warrant conversion.
⚠ அபாய எச்சரிக்கைகள்
Equity dilution risk upon conversion of 5.41 Cr warrants into equity shares.
Subject to shareholder and statutory/regulatory approvals.
Full receipt of funds is contingent on warrant conversion over up to 18 months.
👀 கவனிக்க வேண்டியவை
Track shareholder meeting dates for voting approval, disclosure of specific allottees, and timelines for warrant subscription and conversion.
HOMRE Ltd's Board has approved raising up to ₹12.50 crore via a preferential issue of fully convertible warrants to 8 investors across promoter and non-promoter groups. The fundraise represents approximately 27.8% of the company's current market capitalization of ₹45 crore. Additionally, the Board approved the introduction of HOMRE ESOP 2026 covering up to 3,00,00,000 equity options. Both proposals are subject to shareholder approval at the upcoming 36th AGM scheduled for September 24, 2026.
உச்சம் நம்பிக்கை
என்ன மாறியதுThe Board approved a ₹12.50 crore capital raise via preferential warrants and created a 3-crore share ESOP pool, pending shareholder approval.
ஏன் இது முக்கியம்A ₹12.50 crore capital infusion represents over 46% of TTM revenue (₹27 Cr) and about 28% of market cap (₹45 Cr), significantly enhancing the balance sheet while bringing equity dilution over the next 18 months.
Warrant Issue Size: ₹12,50,00,000Issue Size vs Market Cap: ~27.8%Issue Size vs TTM Revenue: ~46.3%ESOP Pool Size: 3,00,00,000 optionsRelevant Date: ஆகஸ்ட் 25, 2026AGM Date: செப்டம்பர் 24, 2026
📅 குறுகிய காலம்Market focus will be on the pricing formula outcome on the August 25 relevant date and shareholder approval at the September 24 AGM.
📈 நீண்ட காலம்If successfully converted over 18 months, the funds will inject equity capital into the micro-cap business, though existing equity holders will face dilution from both the warrants and the 3 crore ESOP pool.
⚠ அபாய எச்சரிக்கைகள்
Equity dilution for existing public shareholders upon warrant conversion and ESOP exercise
Conversion timeline spans up to 18 months, meaning cash inflows could be staggered
👀 கவனிக்க வேண்டியவை
Track the determination of the final issue price based on the August 25, 2026 relevant date and monitor shareholder voting results at the September 24, 2026 AGM.
📊 கடந்த 7 நாட்கள் — உணர்வு அடிப்படையில் பகுப்பாய்வு செய்யப்பட்ட அறிவிப்புகள்
Aug 19 Board Meeting to Consider Preferential Issue of Warrants and ESOP 2026
HOMRE Ltd has scheduled a board meeting on August 19, 2026, to consider a preferential issue of fully convertible warrants to promoters and non-promoters. This capital-raising move is significant given the company's current financial position, featuring a high debt-to-equity ratio of 10.21 and a net worth of approximately ₹0 Cr. The board will also discuss the implementation of a new Employee Stock Option Plan (ESOP 2026) and approve the notice for the upcoming Annual General Meeting. Investors should note that while the fundraise could provide liquidity, it will lead to equity dilution.
உச்சம் நம்பிக்கை
என்ன மாறியதுThe company is initiating a formal process to raise capital through convertible warrants and introduce an employee stock option scheme.
ஏன் இது முக்கியம்For a micro-cap company with zero net worth and high debt, a preferential issue is a critical step for balance sheet repair or funding operations, though it comes at the cost of shareholder dilution.
Board Meeting Date: ஆகஸ்ட் 19, 2026சந்தை மதிப்பு: ₹36 கோடிDebt-to-Equity Ratio: 10.21TTM வருவாய்: ₹15 கோடிNet Worth: ₹0 கோடி
📅 குறுகிய காலம்The stock may see volatility leading up to and following the August 19 meeting as investors speculate on the warrant pricing and the profile of new investors.
📈 நீண்ட காலம்The long-term impact depends on whether the capital raised is used to reduce debt or fund growth, and the extent of dilution caused by the ESOP and warrant conversions.
⚠ அபாய எச்சரிக்கைகள்
Equity dilution from warrants and ESOPs
Extremely high leverage (D/E 10.21)
Stressed balance sheet with zero net worth
👀 கவனிக்க வேண்டியவை
Monitor the outcome of the August 19 board meeting for specific details on the issue price, the total amount to be raised, and the identity of the non-promoter investors.
HOMRE Ltd Appoints 2 New Independent Directors and Re-designates Board; ED Resigns
HOMRE Ltd (formerly Triton Corp) has announced a significant board restructuring, appointing Mr. Ashok Chopra and Mrs. Puneeta K Sharma as Independent Directors for one-year terms effective July 23, 2026. Additionally, two existing directors were re-designated as Independent, while Executive Director Mr. Sachin Kumar Bhimrajka resigned effective June 22, 2026. These changes occur as the company manages a high debt-to-equity ratio of 10.21 and a market cap of just Rs 39 Cr. The board also approved Q1 FY27 results, noting a minor loss of Rs 0.02 lacs in its subsidiary, Maple Solutions Limited.
உச்சம் நம்பிக்கை
என்ன மாறியதுThe company has overhauled its board by adding two new independent members and losing one executive director, while shifting two other members to independent status.
ஏன் இது முக்கியம்For a micro-cap company with zero net worth and high debt, board independence and governance are critical for potential recovery or strategic pivots.
சந்தை மதிப்பு: Rs 39 கோடிகடன்: Rs 3 கோடிDebt/Equity Ratio: 10.21Subsidiary Q1 Loss: Rs 0.02 lacsDirector Appointment Term: 1 ஆண்டு
📅 குறுகிய காலம்The management changes are unlikely to impact the stock price significantly in the short term, as the market will focus more on the underlying financial health and Q1 results.
📈 நீண்ட காலம்The shift toward a more independent board is structurally positive for governance, but the company's long-term viability depends on addressing its zero net worth and high debt levels.
⚠ அபாய எச்சரிக்கைகள்
High Debt-to-Equity ratio (10.21)
Zero Net Worth
Resignation of an Executive Director
Short 1-year tenure for new independent directors
👀 கவனிக்க வேண்டியவை
Investors should monitor the full Q1 FY27 financial results to assess if the new board composition leads to improved operational performance or debt restructuring, given the company's current financial fragility.
HOMRE Ltd (formerly Triton Corp) approved its Q1 FY27 results, showing its 100% subsidiary, Maple Solutions Limited, generated zero revenue and a nominal loss of Rs 0.02 lacs. The company is undergoing a significant board restructuring, including the resignation of an Executive Director and the appointment of two new Independent Directors. With a market cap of only Rs 39 Cr and a high debt-to-equity ratio of 10.21, the company remains in a precarious financial position with zero net worth as per recent context.
நடுத்தரம் நம்பிக்கை
என்ன மாறியதுThe company approved its quarterly financial results and significantly restructured its board by adding independent oversight and accepting an executive resignation.
ஏன் இது முக்கியம்For a micro-cap company with high leverage (D/E 10.21) and zero net worth, governance changes and the performance of subsidiaries are critical indicators of potential turnaround or further distress.
📅 குறுகிய காலம்The stock may remain volatile due to its micro-cap nature; the board changes are administrative and unlikely to drive immediate price action without a strong P&L surprise.
📈 நீண்ட காலம்Limited structural significance unless the new board can address the negative net worth and high debt levels through a clear business strategy.
⚠ அபாய எச்சரிக்கைகள்
High Debt-to-Equity (10.21)
Zero Net Worth
Micro-cap liquidity risks
Executive Director resignation
👀 கவனிக்க வேண்டியவை
Investors should monitor the full standalone P&L statement to see if the company can sustain the revenue growth seen in the previous two quarters (Mar 2026: Rs 5.96 Cr) given the current zero net worth status.
HOMRE Ltd Appoints 2 New Directors and Approves Q1 FY27 Results; Executive Director Resigns
HOMRE Ltd (formerly Triton Corp) held a board meeting on July 23, 2026, to approve its Q1 FY27 unaudited financial results and overhaul its board structure. The company appointed two new Independent Directors, Mr. Ashok Chopra and Mrs. Puneeta K Sharma, for one-year terms. Additionally, two existing directors were re-designated as Independent, while Executive Director Sachin Kumar Bhimrajka resigned effective June 22, 2026. Financially, its 100% subsidiary, Maple Solutions Limited, reported zero revenue and a marginal loss of Rs 0.02 lacs for the quarter.
உச்சம் நம்பிக்கை
என்ன மாறியதுThe company has significantly restructured its board by adding new independent oversight and accepting the resignation of an executive director, alongside approving its first-quarter results for the new fiscal year.
ஏன் இது முக்கியம்For a micro-cap company with a market cap of only Rs 39 Cr and a high debt-to-equity ratio, changes in board governance and the performance of subsidiaries are key indicators of management stability and fiscal health.
Subsidiary Revenue (Q1 FY27): NILSubsidiary Net Loss (Q1 FY27): Rs 0.02 lacsDebt-to-Equity Ratio: 10.21Market Capitalization: Rs 39 கோடி
📅 குறுகிய காலம்The stock is likely to remain neutral in the short term as the board changes are administrative and the subsidiary's financial impact is negligible.
📈 நீண்ட காலம்The long-term outlook depends on the company's ability to leverage its new board expertise to scale operations beyond its current TTM revenue of Rs 15 Cr and manage its high debt levels.
⚠ அபாய எச்சரிக்கைகள்
High Debt-to-Equity ratio (10.21)
Resignation of an Executive Director
Zero revenue from 100% subsidiary Maple Solutions Limited
Negative Net Worth (Rs 0 Cr)
👀 கவனிக்க வேண்டியவை
Investors should review the detailed Q1 FY27 financial results once fully published to assess if the company can improve its OPM (4.7%) and address its high Debt-to-Equity ratio of 10.21.
⚠️இந்தத் தளம் எவ்வாறு உருவாக்கப்படுகிறது: சந்தைத் தரவுப் பக்கங்கள் NSE/BSE வெளியீடுகள் மற்றும் நிறுவனங்களின் தாக்கல்களிலிருந்து தானாகக் கணக்கிடப்படுகின்றன; செய்திக் கட்டுரைகளும் அறிவிப்புப் பகுப்பாய்வுகளும் AI உதவியுடன் எழுதப்படுகின்றன, மனித மேற்பார்வையுடன்: AI உருவாக்குவதை எங்கள் ஆசிரியர்கள் மதிப்பாய்வு செய்கின்றனர். இரண்டிலும் பிழைகள் இருக்கலாம். எந்தவொரு முதலீட்டு முடிவுக்கு முன்பும் அசல் மூலங்களில் சரிபார்க்கவும். முதலீட்டு ஆலோசனை அல்ல; Flash Finance SEBI-பதிவு பெற்றது அல்ல. நாங்கள் AI-ஐ எவ்வாறு பயன்படுத்துகிறோம்
🎁 ஆரம்பகால ஆதரவாளர்களுக்கு மட்டும் · குறுகிய கால சலுகை
எங்கள் AI பங்குச் சந்தை பகுப்பாய்வு: டெலிகிராம், வாட்ஸ்அப்பில் இலவசம்
⚡ 3500+ நிறுவனங்களை நாங்கள் உடனுக்குடன் கண்காணிக்கிறோம். NSE-யில் ஒரு நிறுவன அறிவிப்பு வெளியானதுமே, எங்கள் AI அதைப் படித்து, சுருக்கி, அதன் தாக்கத்தைச் சில நொடிகளில் உங்களுக்குச் சொல்கிறது.
இதுபோன்ற AI பகுப்பாய்வுக்குக் கட்டணத் தளங்கள் ஆண்டுக்கு ₹1,00,000-க்கும் மேல் வசூலிக்கின்றன. எங்கள் சேனல்களில் இது இலவசம்.
